JPRN-UMIN000046739招募中未知
A prospective observational study on host immunity for development of novel immunotherapeutic strategy in patients with severe respiratory tract infections and sepsis - A prospective observational study on host immunity in patients with severe respiratory tract infections and sepsis
agoya University Hospital0 个研究点目标入组 650 人开始时间: 2022年1月26日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 650
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 90years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Patients who do not receive initial empirical antibiotic treatment 2) Patients with obstructive pneumonia 3) Pneumonia or sepsis occurred in other hospitals and patients who were transferred from other hospitals with a trend toward improvement 4) Patients whose pneumonia or sepsis recurred within 3 days after the last day of antibiotic treatment of a preceding pneumonia or sepsis episode 5) Patients who receive the treatment in outpatient clinics 6) Patients who were enrolled in this study previously 7) Patients over 90 years old 8) HIV positive patients 9) Pregnant women 10) Patients with neutropenia (neutrophil counts <1,000/mm3) 11) Patients with active hematologic malignancies 12) Patients after blood stem cell transplants, including bone marrow transplants 13) Patients treated for co-morbidities with high-dose glucocorticoid
研究者
相似试验
招募中
Unknown
A prospective observational study on host immunity for development of novel immunotherapeutic strategy for treatment and prevention of postoperative infectionsJPRN-UMIN000050678agoya University75
招募中
不适用
An observational study on host immunity in patients with refractory Mycobacterium avium complex pulmonary diseaseMycobacterium avium complex pulmonary diseaseJPRN-UMIN000043426Department of Respiratory Medicine, Nagoya University Graduate School of Medicine40
已完成
不适用
Observational study on the acquisition of immunity in convalescent people with Novel Coronavirus(COVID-19) infectioSARS-CoV-2 infectionJPRN-UMIN000044638Medical Corporation Tsurukamekai Shinjuku Tsurukame Clinic100
已完成
不适用
A prospective observational study of immune-related adverse events, treatment efficacy, and pre-existing autoantibodies in patients with small-cell lung cancer who was treated by immune checkpoint inhibitorPatients with small cell lung cancer who was treated by chemotherapy plus immune checkpoint inhibitor as first line therapyJPRN-UMIN000042962Kobe City Medical Center General Hospital Respiratory Medicine54
已完成
不适用
A prospective observational study of immune-checkpoint inhibitor (Nivolumab) treatment in patients with non-small cell lung canceron-small cell lung cancerJPRN-UMIN000021600Kitasato University School of Medicine52